Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.
about
Structural basis for agonism and antagonism of hepatocyte growth factorMET molecular mechanisms and therapies in lung cancerImmunohistochemical localization of hepatocyte growth factor activator (HGFA) in developing mouse liver tissues. Heterogeneous distribution of HGFA proteinNoncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer.Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effectsDesign and synthesis of 3,3'-biscoumarin-based c-Met inhibitors.Therapeutic targeting of receptor tyrosine kinases in lung cancer.Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice.Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet ReceptorTargeting the HGF-cMET Axis in Hepatocellular Carcinoma.Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET.Growth factor signaling in metastasis: current understanding and future opportunities.Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repairExpression array analysis of the hepatocyte growth factor invasive program.HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics.HGF ameliorates a high-fat diet-induced fatty liver.SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.Inhibitors targeting hepatocyte growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases.The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor.Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis.H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.Physiological Signaling and Structure of the HGF Receptor MET.Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
P2860
Q27663368-6889F998-A187-4E78-BDBA-2EED9A2CC6C4Q28272688-936B0048-3BE7-4994-9321-6C73B1F9D318Q28592355-DCD02153-CB90-4CC0-9A1D-371D7DA4574EQ30484106-1CA394CE-5EA0-4998-8504-DE12293DEBE4Q34588638-C05A815B-4A78-4BFB-BA17-F6BE99770C72Q34792580-8A884365-0F78-4714-A944-4ADF4426A338Q35159738-75EAF8ED-AD25-4519-B144-EBC3FC0402F9Q36158717-E6F568E7-0154-4125-B256-6458070C096FQ36497156-F7972D8E-EC44-4639-9105-7C6BE64676ECQ36558142-37A9F085-BC6B-4E0E-8C35-FC73E7CB9B97Q36766188-89ADBEFB-4032-48D3-90BF-D8AC871CF792Q37883394-F8ABEC74-77AB-4EE5-811C-E296E0E98409Q38019410-C75A70B4-F9B8-4634-8797-5B8D2A6A975DQ38760084-DB69F751-8963-41EF-AC75-11A157B05E00Q38847534-DCCB8717-30F2-4AF6-869A-5E7C59E4E1AAQ39214964-FCAD42AE-7AAD-434D-9484-C36005EB63B7Q40152004-F8C54420-3E20-455C-91AD-777843161C6BQ40749632-13ECF0AC-F413-4F8A-BF31-F07A3291656AQ43167320-A91D4C81-5904-4359-822F-3C43A78C92C8Q44504094-633A4B6F-BA57-4CF0-8606-1E35FD2F63A8Q46331197-E474CA3F-313F-493D-A394-7439010E5B6AQ49952146-94EE7264-2941-43AC-882A-8B37717959D3Q50977853-0D0D8D3A-35E4-4B54-ADCD-985010C2AFEFQ50985118-DA8ADF45-7484-4629-A4DA-52D94B76229AQ54448123-8CFC1F4D-4D00-4657-B58B-FAEFCB331610
P2860
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Disassociation of met-mediated ...... th but facilitates metastasis.
@ast
Disassociation of met-mediated ...... th but facilitates metastasis.
@en
type
label
Disassociation of met-mediated ...... th but facilitates metastasis.
@ast
Disassociation of met-mediated ...... th but facilitates metastasis.
@en
prefLabel
Disassociation of met-mediated ...... th but facilitates metastasis.
@ast
Disassociation of met-mediated ...... th but facilitates metastasis.
@en
P2093
P2860
P1476
Disassociation of met-mediated ...... th but facilitates metastasis.
@en
P2093
D Breckenridge
D P Bottaro
J Jakubczak
W J Larochelle
P2860
P304
P356
10.1128/MCB.20.6.2055-2065.2000
P407
P577
2000-03-01T00:00:00Z